Investors Asset Management Of Georgia Inc Avadel Pharmaceuticals PLC Transaction History

Investors Asset Management Of Georgia Inc

$208 Million
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	SELL	$12.55 - $17.22 $239,705 - $328,902	-19,100 Reduced 17.94%	87,375 $1.48 Million
Q4 2023 Jan 31, 2024	BUY	$9.64 - $14.59 $1.03 Million - $1.55 Million	106,475 New	106,475 $1.5 Million
Q2 2023 Aug 04, 2023	SELL	$8.48 - $16.48 $312,326 - $606,974	-36,831 Reduced 28.16%	93,975 $1.55 Million
Q1 2023 May 01, 2023	SELL	$6.41 - $9.95 $48,075 - $74,625	-7,500 Reduced 5.42%	130,806 $1.2 Million
Q4 2022 Feb 02, 2023	SELL	$5.02 - $10.0 $11,390 - $22,690	-2,269 Reduced 1.61%	138,306 $990,000
Q3 2022 Oct 27, 2022	BUY	$2.57 - $7.31 $1,799 - $5,117	700 Added 0.5%	140,575 $704,000
Q2 2022 Aug 01, 2022	BUY	$1.07 - $6.95 $49,755 - $323,175	46,500 Added 49.8%	139,875 $341,000
Q1 2022 Apr 20, 2022	BUY	$5.46 - $8.29 $36,582 - $55,542	6,700 Added 7.73%	93,375 $638,000
Q4 2021 Feb 03, 2022	BUY	$7.34 - $11.18 $120,376 - $183,352	16,400 Added 23.34%	86,675 $700,000
Q3 2021 Oct 14, 2021	BUY	$6.49 - $9.91 $48,675 - $74,325	7,500 Added 11.95%	70,275 $689,000
Q2 2021 Jul 09, 2021	BUY	$6.73 - $9.05 $48,119 - $64,707	7,150 Added 12.85%	62,775 $422,000
Q1 2021 Apr 21, 2021	BUY	$6.61 - $10.07 $367,681 - $560,143	55,625 New	55,625 $503,000
Q4 2020 Jan 28, 2021	SELL	$5.03 - $7.95 $268,224 - $423,933	-53,325 Closed	0 $0
Q3 2020 Oct 14, 2020	BUY	$5.02 - $8.98 $85,967 - $153,782	17,125 Added 47.31%	53,325 $269,000
Q2 2020 Jul 31, 2020	BUY	$7.25 - $11.75 $26,100 - $42,300	3,600 Added 11.04%	36,200 $292,000
Q1 2020 Apr 21, 2020	SELL	$4.06 - $10.64 $14,209 - $37,240	-3,500 Reduced 9.7%	32,600 $259,000
Q3 2019 Oct 17, 2019	BUY	$1.92 - $4.47 $5,760 - $13,410	3,000 Added 9.06%	36,100 $150,000
Q2 2019 Jul 10, 2019	SELL	$1.09 - $3.19 $1,798 - $5,263	-1,650 Reduced 4.75%	33,100 $96,000
Q1 2019 Apr 17, 2019	BUY	$1.44 - $3.29 $720 - $1,645	500 Added 1.46%	34,750 $50,000
Q4 2018 Jan 22, 2019	BUY	$1.74 - $4.66 $3,480 - $9,320	2,000 Added 6.2%	34,250 $88,000
Q3 2018 Oct 25, 2018	BUY	$4.08 - $7.14 $35,904 - $62,832	8,800 Added 37.53%	32,250 $142,000
Q2 2018 Jul 27, 2018	BUY	$5.89 - $7.78 $49,476 - $65,352	8,400 Added 55.81%	23,450 $144,000
Q1 2018 Apr 11, 2018	BUY	$6.76 - $11.7 $31,772 - $54,990	4,700 Added 45.41%	15,050 $110,000
Q4 2017 Jan 11, 2018	SELL	$8.03 - $11.25 $5,621 - $7,875	-700 Reduced 6.33%	10,350 $85,000
Q3 2017 Nov 02, 2017	BUY	$8.35 - $10.5 $92,267 - $116,025	11,050	11,050 $116,000

Others Institutions Holding AVDL

# of Institutions

Shares Held

1.07M

Call Options Held

Put Options Held

View Full List

About AVADEL PHARMACEUTICALS PLC

Ticker AVDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 60,581,300
Market Cap $650M
Description
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...

More about AVDL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Investors Asset Management Of Georgia Inc , based on Form 13F filings with the SEC.

News

Stay updated on Investors Asset Management Of Georgia Inc with notifications on news.

Account